CG Oncology, Inc. (CGON) vs PTC Therapeutics, Inc. (PTCT)
- CG Oncology, Inc. CGON 59.79 −3.35%
- PTC Therapeutics, Inc. PTCT 59.24 −2.87%
CG Oncology, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. CG Oncology, Inc. and PTC Therapeutics, Inc. are of similar size ($5.5B and $5.1B). CG Oncology, Inc. grew revenue faster over the last twelve months: 840.8% against −42.8%. PTC Therapeutics, Inc. has the higher net margin (−3.80% vs −3,602.7%) and the higher return on invested capital (15.2% vs −4,111.6%). Across the 16 metrics below, PTC Therapeutics, Inc. leads on 13 and CG Oncology, Inc. on 3.
Valuation
Profitability
| Metric | CGON | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | (85.20%) | 92.99% | 65.16% |
| Operating margin | (4,056.18%) | 12.45% | 0.00% |
| Net margin | (3,602.68%) | (3.80%) | 0.00% |
| Free cash flow margin | (2,879.62%) | (29.76%) | 0.00% |
| Return on equity | (26.41%) | 20.64% | (56.36%) |
| Return on assets | (25.11%) | (1.30%) | (48.04%) |
| Return on invested capital | (4,111.64%) | 15.16% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack